Molecular epidemiology and antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus blood culture isolates: Results of the Quebec Provincial Surveillance Programme

Epidemiology and Infection

Volumn 143, Issue 7, 2015, Pages 1511-1518

  Levesque S ^a   Bourgault, A M ^b   Galarneau, L A ^c   Moisan, D ^d   Doualla Bell, F ^a   Tremblay, C ^a,e  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Centre hospitalier regional de Trois Rivieres   (Canada)

^d Department of Microbiology   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antibiotic resistance; bloodstream infections; molecular epidemiology; Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; METICILLIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; CANADA; CHILD; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; CONTROLLED STUDY; FEMALE; GENOTYPE; HEALTHCARE ASSOCIATED INFECTION; HEALTHCARE ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INTRAVENOUS DRUG ABUSE; LUKF PV GENE; LUKS PV GENE; MAJOR CLINICAL STUDY; MALE; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NUC GENE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; UNITED STATES; YOUNG ADULT; BACTEREMIA; CROSS INFECTION; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; QUEBEC; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84926410442     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881400209X     Document Type: Article

References (40)

1. Barber M. Methicillin-resistant staphylococci. Journal of Clinical Pathology 1961; 14: 385-393.
2. Mulvey MR, et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. Journal of Clinical Microbiology 2001; 39: 3481-3485.
3. Mulvey MR, et al. Community-associated methicillinresistant Staphylococcus aureus, Canada. Emerging and Infectious Diseases 2005; 11: 844-850.
4. Main CL, et al. Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Canadian Journal of Infectious Diseases & Medical Microbiology 2005; 16: 343-348.
5. Barton M, et al. Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners. Canadian Journal of Infectious Diseases & Medical Microbiology 2006; 17: 4C-24C.
6. Hawkes M, et al. Community-associated MRSA: superbug at our doorstep. Canadian Medical Association Journal 2007; 176: 54-56.
7. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clinical Microbiology Reviews 2010; 23: 616-687.
8. Nichol KA, et al. Changing epidemiology of methicillinresistant Staphylococcus aureus in Canada. Journal of Antimicrobial and Chemotherapy 2013; 68 (Suppl. 1): i47-i55.
9. Patel M. Community-associated meticillin-resistant Staphylococcus aureus infections: epidemiology, recognition and management. Drugs 2009; 69: 693-716.
10. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. Journal of Infectious Diseases 2008; 198: 336-343.
11. Ito T, et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2001; 45: 1323-1336.
12. Simor AE, et al. Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999. Journal of Infectious Diseases 2002; 186: 652-660.
13. Comité de surveillance provinciale des infections nosocomiales (SPIN-SARM). Provincial surveillance of S. aureus bloodstream infections, Report 2011-2012. Institut national de santé publique du Québec, 2012.
14. Fortin E, et al. Healthcare-associated bloodstream infections secondary to a urinary focus: the Quebec provincial surveillance results. Infection Control and Hospital Epidemiology 2012; 33: 456-462.
15. CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, ninth edition, M07-A9. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute, 2012.
16. CLSI. Performance standards for antimicrobial susceptibility testing, twenty-second informational supplement, M100-S22. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute, 2012.
17. CLSI. Performance standards for antimicrobial disk susceptibility test; approved standard-eleventh edition, M02-A11. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute, 2012.
18. bioMérieux. E-test, antimicrobial susceptibility testing for in vitro diagnostic use, 2010. bioMérieux, Marcyl'Étoile, France.
19. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters (version 2.0). 2012. European Society of Clinical Microbiology and Infectious Diseases.
20. Tawil N, et al. The differential detection of methicillin-resistant, methicillin-susceptible and borderline oxacillin-resistant Staphylococcus aureus by surface plasmon resonance. Biosensor and Bioelectronics 2013; 49: 334-340.
21. Geha DJ, et al. Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. Journal of Clinical Microbiology 1994; 32: 1768-1772.
22. Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128-1132.
23. Harmsen D, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. Journal of Clinical Microbiology 2003; 41: 5442-5448.
24. Golding GR, et al. A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field gel electrophoresis epidemic type using spa typing. Canadian Journal of Infectious Diseases & Medical Microbiology 2008; 19: 273-281.
25. Otter JA, French GL. Community-associated meticillinresistant Staphylococcus aureus: the case for a genotypic definition. Journal of Hospital Infection 2012; 81: 143-148.
26. Davis SL, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. Journal of Clinical Microbiology 2007; 45: 1705-1711.
27. Simor AE, et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance and changing epidemiology, 1995-2007. Infection Control and Hospital Epidemiology 2010; 31: 348-356.
28. Cooke FJ, et al. Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia. Clinical Microbiology and Infection 2010; 16: 921-926.
29. Lloyd-Smith E, et al. Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. Epidemiology and Infection 2010; 138: 713-720.
30. Nichol KA, et al. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study. Diagnostic Microbiology and Infectious Disease 2011; 69: 320-325.
31. Vandenesch F, et al. Community-acquired methicillinresistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerging and Infectious Diseases 2003; 9: 978-984.
32. Couillard M, Tremblay C. 2011-2012 activity report of the Quebec Public Health Laboratory. Institut national de santé publique du Québec, 2013.
33. Wu K, et al. A correlative analysis of epidemiologic and molecular characteristics of methicillin-resistant Staphylococcus aureus clones from diverse geographic locations with virulence measured by a Caenorhabditis elegans host model. European Journal of Clinical Microbiology & Infectious Diseases 2013; 32: 33-42.
34. Tenover FC, et al. Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States hospitals. Antimicrobial Agents and Chemotherapy 2012; 56: 1324-1330.
35. Simor AE, et al. Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008. Antimicrobial Agents and Chemotherapy 2010; 54: 2265-2268.
36. Webster D, et al. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. Diagnostic Microbiology and Infectious Disease 2007; 57: 177-181.
37. Steward CD, et al. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. Journal of Clinical Microbiology 2005; 43: 1716-1721.
38. Zhang K, et al. Coexistence of Panton-Valentine leukocidin-positive and-negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region. Journal of Infectious Diseases 2008; 197: 195-204.
39. Cimolai N. Methicillin-resistant Staphylococcus aureus in Canada: a historical perspective and lessons learned. Canadian Journal of Microbiology 2010; 56: 89-120.
40. Koch AE, Burchall JJ. Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Applied Microbiology 1971; 22: 812-817.